0

Sinusitis - A Pipeline Analysis Report

  • Published: Jun 2018
  • Pages: 62
  • SKU: IRTNTR23117
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

This pipeline analysis report provides detailed insights into the clinical trials landscape of the drug development for sinusitis including molecules at pre-clinical and discovery stage. The report also offers comprehensive information about the therapeutic assessment of the pipeline molecules based on various segmentations such as therapy, route of administration, by territory, therapeutic modality, and target.

Overview of the drug development pipeline for sinusitis 

 In the human body, sinus refers to a hollow space or channel containing blood or a cavity within the bone. The sinus infection occurring behind the head connecting to the nasal cavity, is termed as sinusitis. Sinusitis occurs when the mucus starts building up in the nose and inflates the sinuses. The accumulation of fluid in sinus is the primary cause of sinusitis as this speeds up the process of germ build-up within sinusitis. Various other sinusitis-causing factors consist of viruses, bacteria, and pollutants. Individuals suffering from sinusitis undergo symptoms such as nasal congestion, soreness around eyes, and drainage of thick yellowish-green discharge from nose or throat. Technavio’s market research analysts have identified that the high volume of individuals being diagnosed with sinusitis is driving the significant drug development for therapeutics for sinusitis in the forthcoming years.  

According to this pipeline analysis report, most of the drug development molecules in the pipeline account for the same volume of molecules in the pre-clinical, Phase I, and Phase III drug development stage. Our market research analysts have also identified that almost same amount of drug molecules are under the phase I/II and phase II drug development stage.   

Companies covered

This pipeline analysis report provides a detailed analysis of the companies that are involved in the development of drug development molecules for the treatment of sinusitis. In addition to providing information on the various stages of molecules developed by companies for different indications, this pipeline analysis report also provides information about the drug development molecules discontinued by companies.

Some of the companies covered in this pipeline analysis report are:

  •  0 BIOMEDICAL
  • F.HOFFMANN-LA ROCHE
  • QUORUM INNOVATIONS

Therapeutic assessment of the drug development pipeline for sinusitis by route of administration

  • Oral
  • Inhalation
  • Intranasal
  • Subcutaneous

In this pipeline report analysis, it is observed that most of the therapeutics are being developed for intranasal, oral, and subcutaneous administration. Oral RoA involves the administration of drug through the mouth cavity. Intranasal RoA involves the administration of the drug through the nasal structure and the subcutaneous RoA involves the administration of the drug below the skin.  

Therapeutic assessment of the drug development pipeline for sinusitis by therapeutic modalities

  • Small molecules
  • Biologicals
  • Monoclonal antibody
  • Recombinant protein

According to this pipeline analysis report, two of the molecules that are currently in the drug development pipeline for chondrosarcoma are being developed as monoclonal antibody. These molecules are antibodies made out of identical immune cells that are all clone to a unique parent cell. This pipeline analysis also witnesses same amount of molecules in the biological and small molecules.

 

Technavio also offers customization on reports based on specific client requirement.  

 

Read More Read Less

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION

PART 05: MAJOR REGULATORY AUTHORITIES

  • US
  • Europe
  • China

PART 06: PIPELINE LANDSCAPE

PART 07: COMPARATIVE ANALYSIS

  • Discovery stage molecules
  • Pre-clinical stage molecules
  • Inactive and discontinued molecules

PART 08: INDICATION ANALYSIS

PART 09: THERAPEUTIC ASSESSMENT (THERAPY BASED)

PART 10: THERAPEUTIC ASSESSMENT (ROA BASED)

PART 11: THERAPEUTIC ASSESSMENT BY TARGET

PART 12: KEY COMPANIES

  • Active companies: Category and parameters

PART 13: APPENDIX

  • List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>